Navigation Links
Speech, Swallowing Usually OK After Head & Neck Cancer Therapy
Date:12/20/2010

MONDAY, Dec. 20 (HealthDay News) -- Most head and neck cancer patients can speak and swallow after undergoing combined chemotherapy and radiation treatment, but several factors may be associated with poor outcomes, researchers have found.

The new study included patients who were assessed nearly three years after they were successfully treated with chemoradiotherapy for advanced head and neck cancer.

The U.S. researchers gave a speaking score of 1 through 4 to 163 patients an average of 34.8 months after they completed treatment, and gave a swallowing score of 1 through 4 to 166 patients an average of 34.5 months after treatment. A higher score indicated reduced ability to speak or swallow.

Most of the patients (84.7 percent of those assigned speaking scores and 63.3 percent of those given swallowing scores) had no lasting problems and received a score of 1. Of the 160 patients who were given both speaking and swallowing scores, 96 had a score of 1 in each category, the investigators found.

Factors associated with poorer speaking ability were: being female; a history of smoking; a tumor in the hypopharynx (where the larynx and esophagus meet) or the larynx; or having a tumor that did not respond to the initial dose of chemotherapy.

Factors associated with poorer swallowing ability were: being older; have poor swallowing ability before treatment; neck dissection (surgery to remove lymph nodes and surrounding tissue); and having a tumor in the hypopharynx or larynx.

Dr. Kent Mouw, who was at the University of Chicago at the time of the study and is now at Brigham and Women's Hospital in Boston, and colleagues published their findings in the December issue of the journal Archives of Otolaryngology -- Head & Neck Surgery.

"One of the remarkable features of the data is that most of the patients experienced minimal residual speech or swallowing deficits. Although differences . . . may exist between these patients and healthy subjects, it is encouraging to note that, when day-to-day activities are used as a metric, most patients experience a return to normal or near-normal function," Mouw and colleagues wrote in a journal news release. "Because advances in therapy have led to improved survival in these patients, understanding and controlling adverse effects of treatment should continue to be an active area of investigation," the authors concluded.

More information

The U.S. National Cancer Institute has more about head and neck cancer.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Dec. 20, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New robotic head and neck cancer surgery preserves speech, without scarring
2. Oralflo Pill Swallowing Cup Wins Medical Design Excellence Award, Helps Autism Spectrum Kids and Dysphagia Sufferers Take Medications With No Problem
3. Swallowing safely is no choke
4. Intentional swallowing of foreign bodies and its impact on the cost of health care
5. UC Davis surgeons test innovative device in patient with swallowing disorder
6. Tinnitus Not Usually an Inherited Condition
7. Color, Odor Changes in Urine Usually -- But Not Always -- Harmless, Reports Harvard Women's Health Watch
8. One Month after Major Quake, Ongoing Crises for Haitian Children
9. Ex-President Clinton Said To Be Fine After Heart Procedure
10. Bill Clinton Back Home After Heart Procedure
11. After a Stroke, High Risk for a Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Speech, Swallowing Usually OK After Head & Neck Cancer Therapy
(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: